Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Surgical Science Sweden AB (publ)
  6. Summary
    SUS   SE0014428512

SURGICAL SCIENCE SWEDEN AB (PUBL)

(SUS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
238.5(c) 243(c) 234.5(c) 248(c) 252(c) Last
70 070 73 988 90 156 35 613 34 919 Volume
-8.27% +1.89% -3.50% +5.76% +1.61% Change
More quotes
Estimated financial data (e)
Sales 2021 310 M 35,7 M 35,7 M
Net income 2021 42,0 M 4,84 M 4,84 M
Net cash position 2021 169 M 19,4 M 19,4 M
P/E ratio 2021 305x
Yield 2021 -
Sales 2022 664 M 76,5 M 76,5 M
Net income 2022 88,1 M 10,1 M 10,1 M
Net cash position 2022 243 M 28,0 M 28,0 M
P/E ratio 2022 145x
Yield 2022 -
Capitalization 12 802 M 1 474 M 1 475 M
EV / Sales 2021 40,8x
EV / Sales 2022 18,9x
Nbr of Employees 87
Free-Float 82,6%
More Financials
Company
Surgical Science Sweden AB is a Sweden-based company, which provides with virtual reality simulators for evidence based laparoscopic and endoscopic training. The systems comprise LapSim, EndoSim and TeamSim trainings. Each training combine graphics and cognitive instruction, imply navigation on touch screens and feature tactile feedback technology. The LapSim trainings consist of laparoscopic exercises that range... 
More about the company
Ratings of Surgical Science Sweden AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about SURGICAL SCIENCE SWEDEN AB (PUBL)
09/07SURGICAL SCIENCE SWEDEN : LapSim Annual Update 2021
PU
08/31SURGICAL SCIENCE SWEDEN : Transactions between the largest owners of Surgical Sc..
AQ
08/24SURGICAL SCIENCE SWEDEN : Completes Acquisition Of Simbionix USA
MT
08/24SURGICAL SCIENCE SWEDEN : completes the acquisition of Simbionix
AQ
08/24SURGICAL SCIENCE SWEDEN AB (OM : SUS) completed the acquisition of Simbionix USA..
CI
08/20INTERIM REPORT JANUARY-JUNE 2021 : Continued strong growth, key acquisition foll..
AQ
08/20Surgical Science Sweden AB Publ Reports Earnings Results for the Second Quart..
CI
08/16SURGICAL SCIENCE SWEDEN : Report from the Extraordinary General Meeting of Surgi..
AQ
07/28SURGICAL SCIENCE SWEDEN : Notice of extraordinary general meeting of SURGICAL SC..
AQ
07/28SURGICAL SCIENCE SWEDEN : has completed a directed share issue of SEK 2.7 billio..
AQ
07/28PROTECTED : Surgical Science to acquire Simbionix
PU
07/28SURGICAL SCIENCE SWEDEN : 3D Systems Announces Sale of Medical Simulation Busine..
AQ
07/28SURGICAL SCIENCE SWEDEN : announces intention to carry out a directed share issu..
AQ
07/28SURGICAL SCIENCE SWEDEN : has entered into an agreement to acquire Simbionix
AQ
07/28SURGICAL SCIENCE SWEDEN AB (OM : SUS) entered into a definitive agreement to acq..
CI
More news
News in other languages on SURGICAL SCIENCE SWEDEN AB (PUBL)

- No features available -

More news
Chart SURGICAL SCIENCE SWEDEN AB (PUBL)
Duration : Period :
Surgical Science Sweden AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SURGICAL SCIENCE SWEDEN AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 252,00 SEK
Average target price 302,50 SEK
Spread / Average Target 20,0%
EPS Revisions
Managers and Directors
Gisli Hennermark Chief Executive Officer
Anna Theresa Ahlberg Chief Financial Officer
Roland Bengtsson Chairman
Anders Larsson Chief Technology Officer
Jan Bertil Bengtsson Independent Director
Sector and Competitors